Cargando…
HDAC Inhibitors Repress BARD1 Isoform Expression in Acute Myeloid Leukemia Cells via Activation of miR-19a and/or b
Over the past years BARD1 (BRCA1-associated RING domain 1) has been considered as both a BRCA1 (BReast Cancer susceptibility gene 1, early onset) interactor and tumor suppressor gene mutated in breast and ovarian cancers. Despite its role as a stable heterodimer with BRCA1, increasing evidence indic...
Autores principales: | Lepore, Ilaria, Dell’Aversana, Carmela, Pilyugin, Maxim, Conte, Mariarosaria, Nebbioso, Angela, De Bellis, Floriana, Tambaro, Francesco P., Izzo, Tiziana, Garcia-Manero, Guillermo, Ferrara, Felicetto, Irminger-Finger, Irmgard, Altucci, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859623/ https://www.ncbi.nlm.nih.gov/pubmed/24349422 http://dx.doi.org/10.1371/journal.pone.0083018 |
Ejemplares similares
-
Histone deacetylase inhibitors: clinical implications for hematological malignancies
por: Tambaro, Francesco Paolo, et al.
Publicado: (2010) -
BARD1 Autoantibody Blood Test for Early Detection of Ovarian Cancer
por: Pilyugin, Maxim, et al.
Publicado: (2021) -
Cancer epigenetics: Moving forward
por: Nebbioso, Angela, et al.
Publicado: (2018) -
Antagonizing functions of BARD1 and its alternatively spliced variant BARD1δ in telomere stability
por: Pilyugin, Maxim, et al.
Publicado: (2016) -
HDAC2‐dependent miRNA signature in acute myeloid leukemia
por: Conte, Mariarosaria, et al.
Publicado: (2019)